Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Colorectal Cancer | Research

A new modality of colorectal cancer screening based on chronic disease management

Authors: Mo Liu, Shi-Jun Liu, Ming-Jun Chen, Tingting Ning

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

To develop a new modality of colorectal cancer screening based on chronic disease management (CDM) to improve the participation rate of screening, and maximize the benefits of limited resources.

Methods

Patients under CDM were assigned to screening intervention group (SI) and screening control group1 (SC1), residents from natural community were assigned to screening control group2 (SC2). A parallel controlled community intervention study was performed. Only SI would achieve “one-to-one” intervention services. Meanwhile, 200 subjects were selected from each of the three groups for the Knowledge-Attitude-Practice (KAP) questionnaire before and after intervention, named questionnaire intervention group(QI), questionnaire control group1(QC1) and questionnaire control group2(QC2). The outcome of the intervention was evaluated using the difference-in-differences method and multiple regression analysis.

Results

The preliminary screening participation rate was 43.63%(473/1084) in SI, 14.32%(132/922) in SCI, and 5.87%(105/1789) in SC2. The baseline questionnaire showed low knowledge scores in the three questionnaire groups with no statistically significant differences, while attitude scores in QI and QC1 were significantly higher than QC2. The differences between baseline and terminal showed QI increased larger in knowledge and attitude scores than QC1 and QC2, while no difference was detected between QC1 and QC2.

Conclusion

The colorectal cancer screening model based on chronic disease management effectively improved the screening participation rate, and the “one-to-one” intervention and the inherent characteristics of the patient population under CDM were the core elements of the new modality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, method and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, method and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.CrossRefPubMed
2.
go back to reference Castells A. Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.Ther Adv Gastroenterol2015;(4):21–33. Castells A. Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies.Ther Adv Gastroenterol2015;(4):21–33.
3.
go back to reference Vital Signs. Colorectal Cancer screening, incidence, and Mortality —United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60:884–9. Vital Signs. Colorectal Cancer screening, incidence, and Mortality —United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;60:884–9.
4.
go back to reference Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugan S. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev. 2007;31:3–11.CrossRefPubMed Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugan S. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect Prev. 2007;31:3–11.CrossRefPubMed
5.
go back to reference Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544–573. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544–573.
6.
go back to reference Matsuda T, Ono A, Kakugawa Y, Matsumoto M, Saitoet Y. Impact of screening colonoscopy on outcomes in colorectal cancer. Jpn J Clin Oncol. 2015;45(10):900–5.CrossRefPubMed Matsuda T, Ono A, Kakugawa Y, Matsumoto M, Saitoet Y. Impact of screening colonoscopy on outcomes in colorectal cancer. Jpn J Clin Oncol. 2015;45(10):900–5.CrossRefPubMed
7.
go back to reference Bevan R, Rutter MD. Colorectal Cancer Screening—Who, how, and when? Clin Endosc. 2018;51:37–49.CrossRefPubMed Bevan R, Rutter MD. Colorectal Cancer Screening—Who, how, and when? Clin Endosc. 2018;51:37–49.CrossRefPubMed
8.
go back to reference Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, et al. Effects of Organized Colorectal Cancer Screening on Cancer incidence and mortality in a large community-based Population. Gastroenterology. 2018;155:1383–91.CrossRefPubMed Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, et al. Effects of Organized Colorectal Cancer Screening on Cancer incidence and mortality in a large community-based Population. Gastroenterology. 2018;155:1383–91.CrossRefPubMed
9.
go back to reference Yuan P, Gu J. Meta-analysis of the compliance of Colorectal Cancer Screening in China, 2006–2015. China Cancer. 2017;26(4):241–8. Yuan P, Gu J. Meta-analysis of the compliance of Colorectal Cancer Screening in China, 2006–2015. China Cancer. 2017;26(4):241–8.
10.
go back to reference Han Y, Wu ZT, Li SR, Sheng JQ. Opportunistic screening of Colorectal Cancer and the Situation of China. Chin J Health Manage. 2012;06(2):73–4. Han Y, Wu ZT, Li SR, Sheng JQ. Opportunistic screening of Colorectal Cancer and the Situation of China. Chin J Health Manage. 2012;06(2):73–4.
11.
go back to reference Han Y, Wu ZT, Li SR, Sheng JQ. Opportunistic screening and current status of colorectal cancer screening in China. J New Med. 2012;22:313–4. Han Y, Wu ZT, Li SR, Sheng JQ. Opportunistic screening and current status of colorectal cancer screening in China. J New Med. 2012;22:313–4.
12.
go back to reference Han Y, Wu ZT, Li SR, Sheng JQ. Analysis of 2756 cases of colorectal neoplasm by opportunistic screening. Chin J Misdiagn. 2008;8(9):2130. Han Y, Wu ZT, Li SR, Sheng JQ. Analysis of 2756 cases of colorectal neoplasm by opportunistic screening. Chin J Misdiagn. 2008;8(9):2130.
13.
go back to reference The National Health Commission. China Health Statistics Yearbook 2020. China Union Medical University Press; 2020. p. 268. The National Health Commission. China Health Statistics Yearbook 2020. China Union Medical University Press; 2020. p. 268.
14.
go back to reference Liang CX. The application of Health Management in Chronic Disease Management. Chin COMMUNITY DOCTORS. 2011;13(4):211–2. Liang CX. The application of Health Management in Chronic Disease Management. Chin COMMUNITY DOCTORS. 2011;13(4):211–2.
15.
go back to reference Zhou YQ. Discussing the targets and methods of chronic Diseases Management. Chin Health Service Manage. 2011;10:788–90. Zhou YQ. Discussing the targets and methods of chronic Diseases Management. Chin Health Service Manage. 2011;10:788–90.
16.
go back to reference Liu M, Wang YD, Wang GQ, Liu SJ, Chen MJ, Ding L, et al. Status and influencing factors of knowledge, belief, and practice of Colorectal Cancer Screening between Chronic Disease Patients managed by Community Health Service Center and Community Resident. Chin Prev Med. 2015;16(12):950–4. Liu M, Wang YD, Wang GQ, Liu SJ, Chen MJ, Ding L, et al. Status and influencing factors of knowledge, belief, and practice of Colorectal Cancer Screening between Chronic Disease Patients managed by Community Health Service Center and Community Resident. Chin Prev Med. 2015;16(12):950–4.
17.
go back to reference Geneve N, Kairys D, Bean B, Provost T, Mathew R, Taheri N. Colorectal Cancer Screening Primary Care: Clinics in Office Practice. 2019;46(1):135–48.PubMed Geneve N, Kairys D, Bean B, Provost T, Mathew R, Taheri N. Colorectal Cancer Screening Primary Care: Clinics in Office Practice. 2019;46(1):135–48.PubMed
18.
go back to reference Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64:1158–77.CrossRefPubMed Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64:1158–77.CrossRefPubMed
Metadata
Title
A new modality of colorectal cancer screening based on chronic disease management
Authors
Mo Liu
Shi-Jun Liu
Ming-Jun Chen
Tingting Ning
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02698-3

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.